Minoxidil

This classification denotes a vasodilating agent and antihypertensive agent with the molecular formula C9H15N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5965120SH1, chemically known as 2,6-diamino-4-piperidinopyrimidin-1-oxid but generally known as minoxidil, which bears US NIH Compound Identifier 4201. European Medicines Agency schedules Minoxidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08982MIG. The term MINOXIDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules minoxidil in its Anatomical Therapeutic Chemical (ATC) Classification. MINOXIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule minoxidil under HS 29335995 and SITC 51576. As of Q4 2014, MINOXIDIL remains the US FDA Preferred Term for this commodity. Minoxidil bears US NLM identifiers UMLS ID C0730881 and NCI Concept Code C47623. SMILES: On1c(N)cc(N2CCCCC2)nc1=N.